Modification of the Binding of Sulphamidochlorobenzoic Acid to Human Albumin by Palmitic Acid Contamination of Albumin
Overview
Authors
Affiliations
Palmitic acid a common contaminant of albumin preparations, competitively inhibits the binding of sulphamidochlorobenzoicacid (SCBA) to human albumin thus decreasing its observed affinity. The effect of palmitic acid depends on its concentration, i.e. the purity and concentration of the albumin preparation used. The correct value for SCBA affinity was obtained by correcting the experimental data according to the palmitic acid concentration by use of a multiligand analysis method.
Binding of digitoxin, digoxin and gitoxin to human serum albumin.
Tillement J, Zini R, Lecomte M, dAthis P Eur J Drug Metab Pharmacokinet. 1980; 5(3):129-34.
PMID: 7202430 DOI: 10.1007/BF03189456.
The effects of chronic renal insufficiency on the pharmacokinetics of doxycycline in man.
Houin G, Brunner F, Nebout T, Cherfaoui M, LAGRUE G, Tillement J Br J Clin Pharmacol. 1983; 16(3):245-52.
PMID: 6626415 PMC: 1428002. DOI: 10.1111/j.1365-2125.1983.tb02157.x.
Diseases and drug protein binding.
Tillement J, Lhoste F, Giudicelli J Clin Pharmacokinet. 1978; 3(2):144-54.
PMID: 25156 DOI: 10.2165/00003088-197803020-00004.